PLx Pharma Winddown Overview
- Year Founded
-
2002
- Status
-
Private
- Employees
-
19
- Latest Deal Type
-
M&A
- Investors
-
3
PLx Pharma Winddown General Information
Description
PLx Pharma Winddown Corp Formerly PLx Pharma Inc is a specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard drug delivery platform designed to provide more effective and safer products. The PLxGuard drug delivery platform works by targeting the release of active pharmaceutical ingredients to various portions of the GI tract. It believes this platform has the potential to improve the absorption of many drugs currently on the market or in development and to reduce the risk of stomach erosions and ulcers associated with drugs. VAZALORE is a novel formulation of aspirin clinically shown to provide fast, reliable and predictable platelet inhibition for patients with vascular disease and diabetic patients who may be candidates for aspirin therapy.
Contact Information
Website
www.plxpharma.comCorporate Office
- 8 The Green
- Suite 11895
- Dover, DE 19901
- United States
Corporate Office
- 8 The Green
- Suite 11895
- Dover, DE 19901
- United States
PLx Pharma Winddown Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 21. Merger/Acquisition | 12-Apr-2023 | Completed | Generating Revenue | |||
| 20. PIPE | 30-Sep-2020 | Completed | Generating Revenue | |||
| 19. PIPE | 15-May-2020 | Completed | Generating Revenue | |||
| 18. Secondary Transaction - Open Market | Completed | Generating Revenue | ||||
| 17. PIPE | 01-Mar-2019 | Completed | Generating Revenue | |||
| 16. Reverse Merger | 19-Apr-2017 | Completed | Generating Revenue | |||
| 15. Later Stage VC | 10-Mar-2016 | Completed | Generating Revenue | |||
| 14. IPO | 04-Mar-2016 | Cancelled | Generating Revenue | |||
| 13. Later Stage VC | 08-Jul-2013 | $9M | $32.5M | Completed | Generating Revenue | |
| 12. Later Stage VC (Series G) | 19-Mar-2013 | $8.27M | $23.5M | Completed | Generating Revenue |
PLx Pharma Winddown Comparisons
Industry
Financing
Details
PLx Pharma Winddown Competitors (97)
One of PLx Pharma Winddown’s 97 competitors is Grace Therapeutics, a Corporation company based in Princeton, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Grace Therapeutics | Corporation | Princeton, NJ | ||||
| Harmony Biosciences | Formerly VC-backed | Plymouth Meeting, PA | ||||
| Abeona Therapeutics | Corporation | Cleveland, OH | ||||
| Tricida | Formerly VC-backed | Sacramento, CA | ||||
| Akari Therapeutics | Formerly VC-backed | London, United Kingdom |
PLx Pharma Winddown Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
PLx Pharma Winddown Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Level One Partners | Venture Capital | Minority | ||
| Whitetail Rock Capital Management | Asset Manager | Minority | ||
| Dipexium Pharmaceuticals | Corporation | Minority |
PLx Pharma Winddown Acquisitions (1)
PLx Pharma Winddown’s most recent deal was a Merger/Acquisition with Dipexium Pharmaceuticals. The deal was made on 19-Apr-2017.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Dipexium Pharmaceuticals | 19-Apr-2017 | Merger/Acquisition | Drug Delivery |
PLx Pharma Winddown ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
PLx Pharma Winddown FAQs
-
When was PLx Pharma Winddown founded?
PLx Pharma Winddown was founded in 2002.
-
Where is PLx Pharma Winddown headquartered?
PLx Pharma Winddown is headquartered in Dover, DE.
-
What is the size of PLx Pharma Winddown?
PLx Pharma Winddown has 19 total employees.
-
What industry is PLx Pharma Winddown in?
PLx Pharma Winddown’s primary industry is Pharmaceuticals.
-
Is PLx Pharma Winddown a private or public company?
PLx Pharma Winddown is a Private company.
-
What is PLx Pharma Winddown’s current revenue?
The current revenue for PLx Pharma Winddown is .
-
How much funding has PLx Pharma Winddown raised over time?
PLx Pharma Winddown has raised $74.8M.
-
Who are PLx Pharma Winddown’s investors?
Level One Partners, Whitetail Rock Capital Management, and Dipexium Pharmaceuticals have invested in PLx Pharma Winddown.
-
Who are PLx Pharma Winddown’s competitors?
Grace Therapeutics, Harmony Biosciences, Abeona Therapeutics, Tricida, and Akari Therapeutics are some of the 97 competitors of PLx Pharma Winddown.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
